tradingkey.logo

Biomerica Inc

BMRA

3.160USD

-0.072-2.23%
Market hours ETQuotes delayed by 15 min
8.04MMarket Cap
LossP/E TTM

Biomerica Inc

3.160

-0.072-2.23%
More Details of Biomerica Inc Company
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Company Info
Ticker SymbolBMRA
Company nameBiomerica Inc
IPO dateMar 17, 1980
CEOMr. Zackary S. Irani
Number of employees63
Security typeOrdinary Share
Fiscal year-endMar 17
Address17571 Von Karman Avenue
CityIRVINE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92614
Phone19493792875
Websitehttps://biomerica.com/
Ticker SymbolBMRA
IPO dateMar 17, 1980
CEOMr. Zackary S. Irani
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
158.82K
+24.50%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
19.38K
--
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
10.63K
--
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
10.00K
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
158.82K
+24.50%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
19.38K
--
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
10.63K
--
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
10.00K
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Clinical Lab
627.00K
56.03%
Contract Manufacturing
320.00K
28.60%
OTC
170.00K
15.19%
Physicians’ Office
2.00K
0.18%
By RegionUSD
Name
Revenue
Proportion
United States
404.00K
36.10%
Asia
365.00K
32.62%
Europe
198.00K
17.69%
Middle East
149.00K
13.32%
South America
3.00K
0.27%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Clinical Lab
627.00K
56.03%
Contract Manufacturing
320.00K
28.60%
OTC
170.00K
15.19%
Physicians’ Office
2.00K
0.18%
Shareholding Stats
Updated: Fri, Jun 13
Updated: Fri, Jun 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Irani (Zackary S)
6.24%
Barbieri (Allen)
0.92%
The Vanguard Group, Inc.
0.83%
Potomac Capital Management Inc.
0.82%
Geode Capital Management, L.L.C.
0.77%
Other
90.41%
Shareholders
Shareholders
Proportion
Irani (Zackary S)
6.24%
Barbieri (Allen)
0.92%
The Vanguard Group, Inc.
0.83%
Potomac Capital Management Inc.
0.82%
Geode Capital Management, L.L.C.
0.77%
Other
90.41%
Shareholder Types
Shareholders
Proportion
Individual Investor
10.13%
Investment Advisor
3.16%
Investment Advisor/Hedge Fund
1.39%
Hedge Fund
1.15%
Research Firm
0.11%
Other
84.06%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
71
405.75K
15.94%
-224.41K
2025Q1
76
410.80K
15.63%
-250.78K
2024Q4
75
3.95M
21.57%
-995.41K
2024Q3
72
3.29M
19.49%
-2.27M
2024Q2
72
4.09M
24.25%
-2.17M
2024Q1
69
5.91M
35.06%
-122.92K
2023Q4
64
5.72M
33.95%
-599.64K
2023Q3
64
6.05M
35.94%
-733.42K
2023Q2
65
6.44M
38.42%
-719.23K
2023Q1
74
6.78M
42.10%
-508.01K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Irani (Zackary S)
158.82K
6.24%
+31.25K
+24.50%
Dec 13, 2024
Barbieri (Allen)
23.54K
0.92%
+13.75K
+140.42%
Dec 13, 2024
The Vanguard Group, Inc.
21.13K
0.83%
--
--
Mar 31, 2025
Potomac Capital Management Inc.
20.96K
0.82%
-477.00
-2.22%
Dec 31, 2023
Geode Capital Management, L.L.C.
19.57K
0.77%
+4.76K
+32.13%
Mar 31, 2025
Emerson (Jane)
19.50K
0.77%
+10.63K
+119.72%
Dec 13, 2024
Lu (Gary)
19.38K
0.76%
+19.38K
--
Dec 13, 2024
BlackRock Institutional Trust Company, N.A.
18.64K
0.73%
--
--
Mar 31, 2025
Bulltick Wealth Management, LLC
17.14K
0.67%
+17.14K
--
Mar 31, 2025
Coste (Catherine)
16.10K
0.63%
+10.63K
+194.10%
Dec 13, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI